Quick Answer
ASSEMBLY BIOSCIENCES, INC. reported Cash And Cash Equivalents At Carrying Value of $58.45 million for the year ending 2025.
- ASSEMBLY BIOSCIENCES, INC. showed an increase of +52.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ASSEMBLY BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2005 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $58.45 million | Fiscal year 2024: $38.34 million | Fiscal year 2023: $19.84 million | Fiscal year 2022: $52.42 million | Fiscal year 2021: $45.63 million | Fiscal year 2020: $59.44 million | Fiscal year 2019: $46.73 million | Fiscal year 2018: $41.47 million | Fiscal year 2017: $82.03 million | Fiscal year 2016: $28.58 million | Fiscal year 2015: $27.11 million | Fiscal year 2014: $29.09 million | Fiscal year 2013: $27.06 million | Fiscal year 2012: $20.49 million | Fiscal year 2011: $36.98 million | Fiscal year 2010: $14.57 million | Fiscal year 2009: $81.3 thousand | Fiscal year 2008: $15.9 thousand | Fiscal year 2005: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: